Skip to main navigation Skip to search Skip to main content

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

  • François Mach*
  • , Colin Baigent
  • , Alberico L. Catapano
  • , Konstantinos C. Koskina
  • , Manuela Casula
  • , Lina Badimon
  • , M. John Chapman
  • , Guy G. De Backer
  • , Victoria Delgado
  • , Brian A. Ference
  • , Ian M. Graham
  • , Alison Halliday
  • , Ulf Landmesser
  • , Borislava Mihaylova
  • , Terje R. Pedersen
  • , Gabriele Riccardi
  • , Dimitrios J. Richter
  • , Marc S. Sabatine
  • , Marja Riitta Taskinen
  • , Lale Tokgozoglu
  • Olov Wiklund, Stephan Windecker, Victor Aboyans, Jean Philippe Collet, Veronica Dean, Donna Fitzsimons, Chris P. Gale, Diederick Grobbee, Sigrun Halvorsen, Gerhard Hindricks, Bernard Iung, Peter Jüni, Hugo A. Katus, Christophe Leclercq, Maddalena Lettino, Basil S. Lewis, Bela Merkely, Christian Mueller, Steffen Petersen, Anna Sonia Petronio, Marco Roffi, Evgeny Shlyakhto, Iain A. Simpson, Miguel Sousa-Uva, Rhian M. Touyz, Djamaleddine Nibouche, Parounak H. Zelveian, Peter Siostrzonek, Ruslan Najafov, Frank Visseren, , ,
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Downloads (Pure)
Original languageEnglish
Pages (from-to)140-205
Number of pages66
JournalAtherosclerosis
Volume290
Early online date31 Aug 2019
DOIs
Publication statusPublished - 1 Nov 2019

Keywords

  • Apolipoprotein B
  • Cholesterol;
  • Dyslipidaemias
  • Familial hypercholesterolaemia
  • Guidelines
  • High-density lipoproteins
  • Lipoprotein remnants
  • Lipoprotein(a)
  • Low-density lipoproteins
  • Total cardiovascular risk
  • Treatment (adherence)
  • Treatment (drugs)
  • Treatment (lifestyle)
  • Triglycerides
  • Very low-density lipoproteins

Cite this